Notably, the declining trend of TNFRSF18 expression was validated in public datasets, suggesting that TNFRSF18 could act as a promising biomarker for early CRC screening and indicate T cell exhaustion. The gene discussed is TNFRSF18; the disease is colorectal carcinoma.